59Indexed trials
Market Rank #41 · Evidence Tier A
Hong Kong
Neuroscience Intelligence
Hong Kong neuroscience intelligence: 59 indexed trials, 4 institutions, research score 25.27.
20Recruiting
4Research institutions
25.3Research score
Evidence profile
20Sponsors
14Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 25 · ML priority 25 · Confidence 85 · Evidence 25.3
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
autism9trials
stroke8trials
depression7trials
alzheimers7trials
epilepsy5trials
parkinsons4trials
adhd4trials
other_neurology2trials
pain_neuropathy2trials
schizophrenia2trials
Leading indexed sponsors
The Hong Kong Polytechnic University12trials
The University of Hong Kong12trials
Chinese University of Hong Kong11trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials
Education University of Hong Kong3trials
Merck Sharp & Dohme LLC3trials
Hong Kong Metropolitan University1trials
NovoCure GmbH1trials
Region Skane1trials
Shionogi1trials